MNDY › analyze
MNDY · Analyze
2026-09-05 · $91.07 · Technology / Software–Application · Israel (FPI) Baseline: analyze-2026-08-10.md (WATCH 5.5)
One line: 26 days on, nothing material has changed and nothing was due to. No new print, no new buyback, no Potter ruling, no core price increase. Price +2.8%. The verdict, the fair value, and the reason to wait are all unchanged — the reason to wait is a date (Q3, ~Nov 9), not a doubt. This is a re-check, not a re-derivation: the 8/10 report stands.
Why this is a re-check, not a full rebuild
The 8/10 analysis was written the morning Q2 printed and is exhaustive (share-count pitfall
retraction, the tax-reversal earnings artifact, the pricing-lap test, moat, valuation, sentiment).
The single catalyst it turns on — the first post-pricing-lap quarter — does not report until
~2026-11-09. Between an earnings-day deep-dive and the next print, a /analyze can only
re-verify that the inputs still hold. They do. Re-deriving 550 lines that would land on the same
verdict is exactly the re-work the KB protocol exists to prevent. Claims carried forward from the
baseline are cited, not re-argued.
Claim ledger — every prior claim, re-tested
| # | Baseline claim | Status | Note |
|---|---|---|---|
| 1 | Share count 42.27M, single-class, Yahoo correct (pitfall retracted) | carried | fin.py still reads 42.27M / EV $3.01B. Nothing restated. |
| 2 | FY25 earnings ~100% tax-reversal + interest; both props gone in 2026 | carried | No new filing since Q2 6-K. Still void for valuation. |
| 3 | Growth cliffs 22% → 16% as the 2024 price increase laps end-Q2 | untested | The point of the Q3 print. Nothing between prints can move it. |
| 4 | SBC decline is a share-price artifact; RSUs +86%; total comp rising | carried | Filing-based; no new data. |
| 5 | FY26E adj FCF guided down 10–13% in dollars on +20% revenue | carried | Guide unchanged. |
| 6 | Buyback backstop 100% exhausted, no successor | carried / confirmed | Web + filings: still exhausted, no new authorization announced through 2026-09-05. |
| 7 | Moat 5.5 — switching-cost/data-gravity (not network effect), thin in SMB tail | carried | No change. |
| 8 | Fair value $66–124, central ~$92; roughly fair at spot | refreshed | At $91.07 vs the $88.62 base, still inside the band, still ~central. No margin of safety. |
| 9 | Analyst consensus: PTs reset, ratings didn't; zero sells; mean ~$110 | drifted (minor) | See below — more PT trims + two downgrades to Neutral. Direction of travel, not a re-rate. |
| 10 | Insider selling stopped 2025-12-09, silent through the drawdown (FPI, no 10b5-1) | carried | No new Form 144/6-K disclosure. |
| 11 | Potter v. monday.com pending, docket status unknown post-2026-05-11 | carried | No ruling surfaced. |
No claim flipped. One drifted mildly (analyst tone, item 9). One remains the whole game (item 3).
What actually moved in 26 days
- Price: $88.62 → $91.07 (+2.8%). Crossed back above its 200-day MA on 8/28. Noise.
- Analyst actions (8/10–8/11, post-Q2): UBS Neutral PT $85→$95; Citi keeps Buy but $154→$132; Wells Fargo keeps OW $130→$120; TD Cowen reiterates Buy $110; BTIG reiterates Buy $105; Piper Neutral $90. Two downgrades to Neutral — Cantor (OW→Neutral, $112→$90) and Wolfe (Outperform→Peer Perform). Mean PT essentially flat at ~$109. Pattern is unchanged from the baseline: price targets keep grinding down inside mostly-unchanged Buy ratings — the "unfinished business" the 8/10 report flagged is still unfinished, now with a two-notch start.
- News flow: all valuation-commentary (Simply Wall St ×3, Zacks, StockStory) debating whether 2.7x P/S is fair after the profitability milestone. No primary-source development — no 8-K/6-K of substance, no buyback, no price increase, no litigation event.
Verdict — WATCH, conviction 5.5/10 (unchanged)
The 8/10 thesis is intact in every particular: a good, fortress-balance-sheet business (88% GM, ~$1.07B net cash, +$135M SBC-adj owner earnings, RPO +34%) whose one decisive unknown — can it grow organically once the 2024 price increase laps? — management has told you resolves negative on the guide, and which the market cannot re-price until Q3. Fair value ≈ price, so you are still not paid to take the deceleration risk in front of the print.
The mild analyst drift (two downgrades, more PT cuts) is directionally consistent with the bear case but changes no number that matters. If anything it makes the setup cleaner: more of the sell side has capitulated to the deceleration, which lowers the bar for a Q3 that merely holds ≥15% to re-rate the name. That asymmetry — [4.0] if growth breaks <13%, [6.5–7.0] if organic lands ≥15% — is the same ~90-day, date-driven setup the baseline described.
Key risks (unchanged): (1) Q3 is the first post-lap quarter, guide already assumes no marketing rebound — a miss re-rates hard; (2) no buyback beneath the stock; (3) AI credits carry COGS and dilute gross margin as they scale; (4) SMB-tail exposure to Microsoft bundling; (5) FPI status — you will never see a founder Form 4.
Disposition — NOT TRACKED (carried from 2026-08-10)
No position; not added to Watchlist.md. The reason is portfolio overlap, not the score. MNDY is a direct competitor of TEAM (held, re-underwritten 2026-08-07 at conviction 6.5), and the KB's own comparison has TEAM accelerating (Cloud 26→26→29→31%) while MNDY decelerates (24→22→16%). Adding the weaker of two direct competitors, into a book already carrying 20+ enterprise-software names, is the wrong side of that trade at any conviction. This argument is unchanged.
Re-entry conditions (from baseline): post-lap organic growth ≥15% (Q3) · organic NDR ≥110% · AI credit ARR disclosed and >3% of revenue (FY27 guide) · a new buyback authorization · price $65–75. Conditions 1–2 alone take it to 6.5–7.0; growth <13% takes it to 4.0.
Next catalyst
Q3 FY26 print, ~2026-11-09 — the quarter, the first without the 2024 pricing tailwind. Watch organic NDR and the $50k+/$500k+ cohort counts; revenue is the least informative line because the lap is already guided. No action and no further analysis is warranted before then unless a new buyback authorization, a Potter ruling, or a core price increase lands first.
Sources: SEC 6-K FY2025 · Yahoo Finance MNDY · Yahoo Finance analyst upgrades/downgrades feed (8/10–8/11 2026).